Active Motif will be closed on Monday, September 7th in observance of Labor Day.

Active Motif has enabled epigenetics, genomics & transcriptomics research since 1999, developing the antibodies, technologies & services researchers use. That work spans chromatin profiling, histone modifications, and DNA methylation analysis. WHAT IS EXCITING ABOUT THE AREA WE WORK IN? Epigenomics is the study of gene expression changes not caused by mutations in the DNA sequence itself. These changes are shaped by factors like early development, environmental exposures, drugs, aging, and diet, and can have a major impact on health and disease. Mapping the epigenetic landscape offers the potential for predictive biomarkers, sometimes identifying disease risk before changes in gene expression even occur. As the layer connecting genomics, transcriptomics, and proteomics, epigenomics is central to multiomics research, generating richer data that can be aggregated into actionable insight. WHAT DOES ACTIVE MOTIF OFFER? For over two decades, Active Motif has developed rigorously validated antibodies and enzymes for epigenetic research, along with patented transposase-based technologies underlying assays such as ATAC-Seq and CUT&RUN for chromatin, histone modification, and DNA methylation analysis. Our Product Development Program brings emerging techniques to market as products researchers can run in-house, or as part of our end-to-end epigenomic services, backed by an in-house bioinformatics platform. We support drug discovery, translational medicine, and mechanistic research across academic, pharmaceutical, and biotechnology labs. Contact us at 877-222-9543 or activemotif.com.

Founded 1999